Investor takes Cyanotech to task over astaxanthin supply

Investor takes Cyanotech to task over astaxanthin supply


An investment firm that now owns almost 13% of the stock of Cyanotech is announcing an effort to push the company to speed up the process of bringing additional astaxanthin supply capacity online. Scott Shuda has a law degree from Georgetown University and is a principal in the firm Meridian OHC Partners.



from Biotech News